Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine pharmacokinetics after local infiltration analgesia in total knee arthroplasty
NL-OMON21012Active, not recruiting
- Sponsor
- Sint Maartenskliniek
- Start
- Nov 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of ropivacaine in postoperative pain, sponsored by Sint Maartenskliniek. Primary endpoints: Mean total maximum serum concentration of ropivacaine, Mean unbound maximum serum concentration of ropivacaine and 2 more. Started Nov 2014; status: active, not recruiting.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NL-OMON21012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON21012.